BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 778669)

  • 1. [Treatment with piribedil in peripheral arterial diseases].
    Gatta L; Corti G; Bernasconi S
    Minerva Med; 1976 May; 67(25):1668-70. PubMed ID: 778669
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of an infusion of piribedil in normal subjects and in patients with peripheral obliterating arterial disease on the blood flow of the lower limbs and on blood, plasma and serum viscosity].
    Forconi S; Guerrini M; Agnusdei D; Di Perri T
    Minerva Med; 1976 May; 67(25):1671-80. PubMed ID: 934519
    [No Abstract]   [Full Text] [Related]  

  • 3. [Objective data on the action of piribedil in disorders of the peripheral arterial circulation].
    Royer RJ
    Minerva Med; 1976 May; 67(25):1656-61. PubMed ID: 778667
    [No Abstract]   [Full Text] [Related]  

  • 4. [Piribedil in arterial diseases].
    Cristol R; Arnaud F
    Nouv Presse Med; 1974 Nov 30-Dec 14; 3(41-43):2573-4. PubMed ID: 4619431
    [No Abstract]   [Full Text] [Related]  

  • 5. [Double-blind study on piribedil in peripheral arterial diseases].
    Milliken JC; Fares CM; O'Connor D
    Minerva Med; 1976 May; 67(25):1662-7. PubMed ID: 778668
    [No Abstract]   [Full Text] [Related]  

  • 6. Action of piribedil in Parkinson's disease: I.V. test and oral treatment.
    Emile J; Chanelet J; Truelle JL; Bastard J
    Adv Neurol; 1975; 9():409-13. PubMed ID: 1096577
    [No Abstract]   [Full Text] [Related]  

  • 7. Indications of piribedil in L-DOPA-treated parkinsonian patients: physiopathologic implications.
    Rondot P; Bathien N; Dumas JL
    Adv Neurol; 1975; 9():373-81. PubMed ID: 1096574
    [No Abstract]   [Full Text] [Related]  

  • 8. [Piribedil (TF 871) in the treatment of arteriopathies of the lower extremities].
    Argenteri A; Moia R; Negri L
    Ann Ital Chir; 1979; 51(2):145-55. PubMed ID: 554489
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical trials of a vasoactive drug in arteriopathies of the limbs].
    Courbier R; Jausseran JM; Reggi M
    Sem Hop Ther; 1977 Jan; 53(1):47-51. PubMed ID: 854750
    [No Abstract]   [Full Text] [Related]  

  • 10. [Piribedil in the treatment of Parkinson disease (author's transl)].
    Nardini M; Sciannandrone R; Fieschi C; De Simone G
    Riv Patol Nerv Ment; 1975; 96(2):103-10. PubMed ID: 778998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Double blind clinical experiences with L.S. 121 (praxilene) in patients with chronic ischemic peripheral syndromes].
    Bianchi G
    Minerva Chir; 1974 Aug; 29(15-16):885-90. PubMed ID: 4607675
    [No Abstract]   [Full Text] [Related]  

  • 12. Actions of dopaminergic agonists in parkinsonism.
    McDowell FH; Sweet R
    Adv Neurol; 1975; 9():367-71. PubMed ID: 1096573
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of peripheral circulation disorders of lower extremities with Flunarizine and papaverine].
    Brugmans J; Jageneau A; Adriaensen H
    Med Welt; 1977 Jun; 28(23):1056-64. PubMed ID: 886962
    [No Abstract]   [Full Text] [Related]  

  • 14. [Controlled clinical study of piribedil in cerebrovascular insufficiency].
    Bartoli G; Wichrowska E
    Clin Ter; 1976 Jul; 78(2):141-51. PubMed ID: 795593
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopaminergic agonist effects on Parkinsonian clinical features and brain monamine metabolism.
    Rinne UK; Sonninen V; Marttila R
    Adv Neurol; 1975; 9():383-92. PubMed ID: 1096575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Action of nitrates on pressure and volume in the peripheral circulation of patients with coronary heart disease and with peripheral arterial occlusive diseases].
    Caesar K; Niemeyer H; Hossmann V; Saborowski F
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1738-41. PubMed ID: 347799
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on piribedil in Parkinsonism.
    Lieberman AN; Shopsin B; Brun YL; Boal D; Zolfaghari M
    Adv Neurol; 1975; 9():399-407. PubMed ID: 125032
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopaminergic mechanisms in patients with extrapyramidal disease.
    Chase TN; Shoulson I
    Adv Neurol; 1975; 9():359-66. PubMed ID: 1146660
    [No Abstract]   [Full Text] [Related]  

  • 19. [International symposium on piribedil].
    ZFA (Stuttgart); 1979 Jan; 55(3):172-4. PubMed ID: 33499
    [No Abstract]   [Full Text] [Related]  

  • 20. [Controlled clinical study on the activity and tolerance of Trivastan].
    Nicrosini F; Pasotti C
    Minerva Med; 1976 May; 67(26):1745-50. PubMed ID: 778674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.